This is the first community-driven evaluation of the outcomes of Portugal’s decriminalisation of people who use drugs. Introduced in 2001, Portugal’s model of decriminalisation has been hugely influential and is frequently referred to as an example of legislative reform that has improved public health, social order, and the health and wellbeing of people who use drugs. This document builds on INPUD’s Consensus Statement on Drug Use Under Prohibition: Human Rights, Health, and the Law. Our Consensus Statement collates a declaration of 10 rights of people who use drugs that are commonly violated. In order to realise these fundamental human rights, INPUD emphasised a list of 24 demands which must be met, the first of which is decriminalisation: “People who use drugs, and drug use, must be decriminalised.” Our Consensus Statement was driven by global consultations with representatives of drug user rights organisations all over the world, and their emphasis on the importance of decriminalising both drug use and people who use drugs was consistently and vocally articulated. This document therefore demonstrates the outcomes, both the positives and the shortcomings, of Portugal’s model of decriminalisation. Importantly, it establishes that Portugal’s decriminalisation of people who use drugs is not – as is claimed – a full decriminalisation.
International Overdose Awareness Day: Remembering Dan Bigg
Today is International Overdose Awareness Day. Today, we strive to raise awareness of drug overdose; we strive to end these tragic deaths. We mourn the tragic and untimely passing of Dan Bigg, the founder and Executive Director of the Chicago Recovery Alliance. Dan was a pioneering force behind take-home naloxone programmes in the US and beyond. He worked hard to ensure that naloxone was in the hands of those who needed it the most, that naloxone was in the hands of communities of people who use drugs.
INPUD stands in solidarity with people who use drugs all over the world, as well as the community at large worldwide, in their observance of International Overdose Awareness Day. For further details, please see the International Overdose Awareness Day website for detailed information regarding events, tributes, activities, and naloxone trainings.
Guidance For International And Regional Actors Responding To Acute Violence Against Key Populations
As the violence directed at members of key populations most affected by HIV — gay, bisexual, and other men who have sex with men; people who inject drugs; sex workers; and transgender people — intensifies and becomes “acute” in many parts of the globe, this brief offers guidance to international and regional actors who wish to be part of an effective and coordinated response. International and regional actors who may benefit from this guidance include, but are not limited to, key population networks, governmental bodies, donors, embassies, security experts, nongovernmental organizations (NGOs), media, research institutions, United Nations (UN) agencies or offices, and human rights organizations operating globally or regionally.
INPUD - alongside numerous other drug user networks and harm reduction organisations - have written to the Responsible Alderman for Health Care (Wethouder) Ms. Kukenheim, emphasising we are deeply concerned by the decision of International AIDS Society (IAS) and the Public Health Service of Amsterdam (GGD, Amsterdam) to exclude naloxone as a component of harm reduction services at AIDS 2018.
This contribution is in response to the request of the Office of the High Commissioner for Human Rights (OHCHR) for relevant information with regard to the implementation of Our Joint Commitment to Effectively Addressing and Countering The World Drug Problem, the 2016 United Nations General Assembly Special Session On The World Drug Problem Outcome Document. This submission considers the relevant operational recommendations within the Outcome Document and analyses their relationship to the human rights, lives and experiences of people who use drugs. This submission has been prepared by drawing from available data and from prior consultations with people who use drugs globally.